Liam is an Associate at F-Prime, where he focuses on early-stage investments in enterprise software and frontier technologies. Prior to joining F-Prime, he was a consultant at Bain & Company in the Private Equity Group, working with leading private and growth equity firms on software commercial due diligences.
Liam is a graduate of Swarthmore College, where he received degrees in Economics and Political Science, and was a student-athlete.
Nikhil is a Principal at F-Prime, where he spearheads the firm’s efforts in healthcare growth equity. His primary focus is to partner with rapidly growing, capital efficient businesses in healthcare software and services.
Prior to joining F-Prime, Nikhil worked at Juxtapose, a creation-oriented investment firm focused on healthcare and technology, where he spent 2 years incubating a new business venture in the pharmaceutical services ecosystem. Prior to Juxtapose, Nikhil spent 13 years at Silversmith Capital Partners and TA Associates, where he closed 12 growth-stage investments across healthcare and enterprise software. He began his career as a technology investment banker at Evercore.
Nikhil has a BS in Economics from The Wharton School at the University of Pennsylvania, with concentrations in Finance and Management.
Olivia Carlson is a Senior Associate at F-Prime, focusing on investments in healthcare technology and services companies. Prior to joining F-Prime, she was an investor at M33 Growth, where she assessed investment opportunities and supported their portfolio of growth-stage healthcare companies. Olivia also worked in strategy consulting for EY-Parthenon’s healthcare team. She started her career as a certified nursing assistant, working for a home health and hospice company throughout college.
Olivia holds a B.A. from Williams College, where she majored in Pre-Medical Studies and Psychology.
Chance is an Associate at F-Prime, where he focuses on early-stage investments in enterprise software. Before joining F-Prime, he was a consultant in Accenture’s Software & Platforms Strategy practice, advising leading hyperscalers and technology companies on go-to-market, product, and market expansion strategies.
Chance holds a B.S. in Managerial Economics from the University of California, Davis.
Jingwei is a Senior Associate at F-Prime, investing at the intersection of fintech and digital assets, with a focus on the core infrastructure that underpins modern financial and economic systems.
Earlier in his investing career, Jingwei focused exclusively on fintech. That experience shaped his conviction that while application-layer innovation can meaningfully expand access and improve usability, the next wave of progress depends on modernizing the underlying infrastructure. He now focuses on digital assets as one of the core building blocks enabling that transition across payments, private markets, and capital markets.
Before joining F-Prime, Jingwei worked at Boston Consulting Group, where he developed a ground-level understanding of how large organizations evaluate growth, risk, and technology adoption. He began his career at the Bank of England, gaining rare, inside perspective on how the financial system itself is constructed and governed at its core.
Jingwei holds an MSc in Finance from Imperial College London. His exposure to digital assets began in 2017, when he helped launching a blockchain-native digital bank that raised $20 million via a public token sale.
Natasha Rodgers is an Associate in F-Prime’s London team, working across the life sciences sub-sectors including therapeutics and medical technology. Prior to joining F-Prime, Natasha was an associate consultant at Bain & Company. She also worked as a junior doctor in Edinburgh and Oxford with a particular focus area in Intensive Care.
Natasha holds an MB BChir from Cambridge University and an A.B. in Molecular and Cellular Biology from Harvard University.
Jack Neureuter is a Senior Associate at F-Prime focused on early-stage crypto investments. Prior to joining F-Prime, Jack was an investor at Avon Ventures and a research analyst for Fidelity Digital Assets. Jack’s time as a crypto-focused research analyst has served as a foundation to better understanding the evolving digital asset landscape.
Jack holds a degree in Finance from UMass Amherst. His interest in the crypto space was sparked in 2017 with his initial encounter with Bitcoin.
Bala Varadhan is a Principal at F-Prime focused on early-stage crypto, blockchain, and Web3 investments. Before joining F-Prime, Bala was with Avon Ventures and previously honed his expertise at the Boston Consulting Group (BCG), where he specialized in private equity due diligence and growth strategy. Bala’s career also includes roles in private equity and law, which have equipped him with a strong foundation in investment and transactional analysis.
Bala holds an MBA from the Kellogg School of Management, a JD from the Pritzker School of Law, and dual B.A.s in Economics and Liberal Arts from The University of Texas at Austin. His interest in the crypto space began in 2013 with his initial exposure to Bitcoin.
Sachin Patodia is a Partner at F-Prime. Prior to joining F-Prime, Sachin founded Avon Ventures and accumulated nearly two decades of experience at Fidelity’s Asset Management group as a portfolio manager on the equities team. Sachin’s investment expertise began during his early years in product management at various tech startups, providing him with a background in both finance and technology.
Sachin earned an MBA from the Wharton School of Business and holds dual degrees from the University of Pennsylvania, a B.S.E. in Computer Science, and a B.S. in Economics. His passion for emerging technologies sparked his early involvement with Bitcoin in 2014.
Raj Basak is a Senior Associate with F-Prime and works across the healthcare sub-sectors including therapeutics, medical technology, and life-sciences tools. Prior to joining F-Prime, Raj was a member of the Healthcare Investment Banking team at Goldman Sachs in New York where he worked on over $15 billion in announced financing and M&A transactions across biopharma.
Raj received his PhD in Molecular Biophysics & Biochemistry from Yale University and was a part of the Program in Physics, Engineering, and Biology (PEB). Raj’s doctoral research focused on studying the biophysical mechanisms underlying nociception in sensory neurons. While in graduate school, Raj was also a Canaan-Yale fellow with Canaan Partners and an analyst with Certara.
Prior to graduate school, Raj worked in laboratories at Columbia University Medical Center and Brown University. His research has been published in Biophysical Journal, Nature, Science Translational Medicine, among others. Raj also holds a B.S. in Physics with Research Honors from The Macaulay Honors College at The City College of New York, where he was awarded the Ward medal. His undergraduate thesis focused on interrogating field theory approaches to quantum tunneling.